CryoCath makes appointment
This article was originally published in Scrip
Executive Summary
CryoCath Technologies (Canada), a medical technology company focused on cryotherapy products to treat cardiac arrhythmias, has appointed Frank Vandeputte vice-president, Europe. Based in CryoCath's new European headquarters in Leiden, the Netherlands, Mr Vandeputte will be responsible for leading the European business operation. He joins the company with more than 20 years' experience in the medical device industry. Most recently, he served as area vice-president Benelux and Nordic for the Sorin Group, based in Brussels.